Latest California Healthline Stories
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Battle Lines Are Drawn Over California Deal With Kaiser Permanente
A controversial proposal to grant HMO giant Kaiser Permanente a no-bid statewide Medi-Cal contract is headed for its first legislative hearing amid vocal opposition from a coalition of counties, competing health plans, community clinics, and a national health care labor union.
Washington State Retools First-in-the-Nation Long-Term Care Benefit
The WA Cares Fund program, which would provide workers in the state a lifetime benefit of $36,500, was set to begin collecting money through a payroll tax in January, but it was delayed while lawmakers made adjustments to address equity problems. Now the payroll deductions will begin in July 2023, and benefits will become available in 2026.
Journalist Puts in a Plug for Better Sleep Cycles During the Pandemic
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
How the Test-to-Treat Pillar of the US Covid Strategy Is Failing Patients
The federal “test-to-treat” program was designed to be a one-stop shop for people to get tested for covid and to receive treatment. But as covid cases rise again, many communities have no participating locations, and website bugs make it difficult to book an appointment at the biggest participant.
Readers and Tweeters Sound Alarm Over Nurse’s Homicide Trial
KHN gives readers a chance to comment on a recent batch of stories.
Attendance Plummets at LA Covid Vaccination Events
Across Los Angeles County, few people are showing up at covid vaccination drives even though nearly 2 million residents remain unvaccinated.
Se desploma la asistencia a eventos de vacunación contra covid en Los Ángeles
A medida que las infecciones por covid han ido disminuyendo, también lo ha hecho el interés en las vacunas, a pesar de que estas dosis son altamente efectivas para evitar enfermarse de gravedad y morir a causa del virus.
KHN’s ‘What the Health?’: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
A Travel Nurse Leaves Fears of Hospital Drug Tampering Across Three States
Kentucky nurse Jacqueline Brewster is accused of tampering with opioids in Tennessee and West Virginia, possibly contaminating drugs given to hospital patients.